Cereplast, Inc. (CERP) Misses Q4 Views; Reaffirms Outlook
Tweet
Share
E-mailGet Alerts CERP Hot Sheet
Join SI Premium – FREE
Cereplast, Inc. (NASDAQ: CERP) reported Q4 loss of $0.14, $0.04 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $3.9 million versus the consensus estimate of $5.05 million.
Reaffirms outlook.
Reaffirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
- Kyverna Therapeutics, Inc. (KYTX) Tops Q2 EPS by 45c
- Aardvark Therapeutics (AARD) Tops Q2 EPS by 21c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
